Bedum, Netherlands

Durk Dijkstra

This inventor holds 6 USPTO granted patents. Top assignees: Axon Biochemicals B.v., H. Lundbeck A/s. Active years: 2004-2012.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Durk Dijkstra. Retrieved from https://idiyas.com/inventor/durk-dijkstra

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


% Patents Active = 50.0

Average Co-Inventor Count = 3.6

ph-index = 1

Forward Citations = 4(Granted Patents)


Company Filing History:


Years Active: 2004-2012

Loading Chart...
6 patents (USPTO):Explore Patents

Title: Durk Dijkstra: Innovator in Pharmaceutical Chemistry

Introduction

Durk Dijkstra is a notable inventor based in Bedum, Netherlands. He has made significant contributions to the field of pharmaceutical chemistry, particularly in the development of compounds for treating various medical conditions. With a total of 6 patents to his name, Dijkstra's work has the potential to impact the treatment of serious diseases.

Latest Patents

Dijkstra's latest patents include innovative compounds such as "Phenylethylamines and condensed rings variants as prodrugs of catecholamines." These compounds are designed for use in pharmaceutical compositions aimed at treating conditions like Parkinson's disease, psychoses, Huntington's disease, impotence, renal failure, heart failure, and hypertension. The detailed chemical structures and formulations outlined in his patents demonstrate a sophisticated understanding of medicinal chemistry.

Career Highlights

Throughout his career, Dijkstra has worked with prominent companies in the pharmaceutical industry, including Axon Biochemicals B.V. and H. Lundbeck A/S. His experience in these organizations has allowed him to refine his expertise and contribute to groundbreaking research in drug development.

Collaborations

Dijkstra has collaborated with several professionals in his field, including Bastiaan Johan Venhuis and Hakan Wikstrom. These partnerships have likely enhanced his research and innovation capabilities, leading to the successful development of his patented compounds.

Conclusion

Durk Dijkstra's contributions to pharmaceutical chemistry are noteworthy, with his innovative patents paving the way for advancements in medical treatments. His work exemplifies the importance of research and collaboration in the pursuit of effective healthcare solutions.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…